Back
Marinus Pharmaceuticals Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
31
MRNS
Marinus Pharmaceuticals
Last Price:
0.34
Seasonality Move:
12.73%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Marinus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.33 | Buy |
| 20-day SMA: | 1.19 | Sell |
| 50-day SMA: | 1.41 | Sell |
| 200-day SMA: | 3.73 | Sell |
| 8-day EMA: | 0.52 | Sell |
| 20-day EMA: | 0.96 | Sell |
| 50-day EMA: | 1.29 | Sell |
| 200-day EMA: | 3.12 | Sell |
Marinus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 23.83 | Sell |
| Chaikin Money Flow: | 1451987 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Marinus Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marinus Pharmaceuticals Stock
Is Marinus Pharmaceuticals Stock a Buy?
- Marinus Pharmaceuticals share price is 0.34 while MRNS 8-day simple moving average is 0.33, which is a Buy signal.
- The stock price of MRNS is 0.34 while Marinus Pharmaceuticals 20-day SMA is 1.19, which makes it a Sell.
- Marinus Pharmaceuticals 50-day simple moving average is 1.41 while MRNS share price is 0.34, making it a Sell technically.
- MRNS stock price is 0.34 and Marinus Pharmaceuticals 200-day simple moving average is 3.73, creating a Sell signal.
MRNS Technical Analysis vs Fundamental Analysis
Sell
31
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy or a Sell?
-
Marinus Pharmaceuticals stock is rated a Sell
The current Marinus Pharmaceuticals [MRNS] share price is $0.34. The Score for MRNS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Marinus Pharmaceuticals Stock Info
Market Cap:
18.46M
Price in USD:
0.34
Share Volume:
2.04M
Marinus Pharmaceuticals 52-Week Range
52-Week High:
11.26
52-Week Low:
0.26
Sell
31
Marinus Pharmaceuticals (MRNS)
is a Sell
Marinus Pharmaceuticals Share Price Forecast
-
What is the Marinus Pharmaceuticals stock price today?
The Marinus Pharmaceuticals stock price is 0.34 USD today. -
Will MRNS stock go up or go down?
Marinus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Marinus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marinus Pharmaceuticals is overvalued.
Is Marinus Pharmaceuticals Stock a Buy?
- Marinus Pharmaceuticals share price is 0.34 while MRNS 8-day exponential moving average is 0.52, which is a Sell signal.
- The stock price of MRNS is 0.34 while Marinus Pharmaceuticals 20-day EMA is 0.96, which makes it a Sell.
- Marinus Pharmaceuticals 50-day exponential moving average is 1.29 while MRNS share price is 0.34, making it a Sell technically.
- MRNS stock price is 0.34 and Marinus Pharmaceuticals 200-day simple moving average is 3.12, creating a Sell signal.
Fundamental Analysis of Marinus Pharmaceuticals
Is Marinus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.62 per share, and an increase next year of $1.17 per share.
Technical Analysis of Marinus Pharmaceuticals
Should I short Marinus Pharmaceuticals stock?
- MRNS Moving Average Covergence Divergence (MACD) indicator is -0.37, suggesting Marinus Pharmaceuticals is a Sell
- Marinus Pharmaceuticals Relative Strength Index (RSI) is 23.83, which suggest Marinus Pharmaceuticals is oversold
- The Bollinger Bands (25) for Marinus Pharmaceuticals is ( - ), which suggest Marinus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Marinus Pharmaceuticals is ( - ), which suggest Marinus Pharmaceuticals is a Buy
* Marinus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.